Cellectis is formerly owned by Odyssée Venture, through Odyssee Venture Funds, since 2002.

When did Odyssée Venture acquire Cellectis?

Odyssée Venture acquired Cellectis in 2002 and exited after 5 years.

Has Cellectis been sold?

Yes. Cellectis was exited in 2007 via IPO.

Home/Companies/Biotech/Cellectis

Cellectis

Biotech·

France·Exited 2007·Held 5yr

Cellectis is a biotech company, headquartered in France.

Entry

2002

Hold

5yr

Exit

2007

Est. EV

–

Investor

Odyssée Venture

Key facts

HQFrance

SectorBiotech

StatusAcquired

French biopharmaceutical company developing gene edited cell therapies for cancer, listed on Euronext Alternext in February 2007 and later…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Odyssee Venture Funds

6 comparable biotech deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member?

Data refreshed weekly · Sourced from public filings